Leaflet ESTRACYT R 140mg capsules
Indicated for: cancer
Route of administration: oral
Substance: estramustine (antineoplastic agent)
ATC: L01XX11 (Antineoplastic and immunomodulating agents | Other antineoplastic agents)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Estramustine is a medication used in the treatment of advanced prostate cancer. It works by combining hormonal and cytotoxic effects, inhibiting the growth and multiplication of cancer cells.
Estramustine is administered orally as capsules, according to the oncologist's instructions. The dose and duration of treatment are determined individually, depending on the stage of the disease and the patient's response to therapy.
Side effects may include nausea, vomiting, swelling of the limbs, fatigue, digestive disorders, or, rarely, allergic reactions and an increased risk of thrombosis. Medical monitoring is necessary throughout the treatment.
Estramustine is an important option for patients with advanced prostate cancer, helping to slow disease progression and improve quality of life.
General data about ESTRACYT R 140mg
- Substance: estramustine
- Date of latest medicines list: 01-07-2013
- Product code: W07049003
- Concentration: 140mg
- Pharmaceutical form: capsules
- Quantity: 100
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.